Annual Total Expenses
$25.37 M
-$30.12 M-54.28%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual total expenses is $25.37 million, with the most recent change of -$30.12 million (-54.28%) on December 31, 2023.
- During the last 3 years, AVTX annual total expenses has fallen by -$28.63 million (-53.02%).
- AVTX annual total expenses is now -71.02% below its all-time high of $87.53 million, reached on December 31, 2021.
Performance
AVTX Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Expenses
$13.11 M
+$3.64 M+38.41%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly total expenses is $13.11 million, with the most recent change of +$3.64 million (+38.41%) on September 30, 2024.
- Over the past year, AVTX quarterly total expenses has increased by +$3.64 million (+38.41%).
- AVTX quarterly total expenses is now -57.78% below its all-time high of $31.05 million, reached on March 31, 2021.
Performance
AVTX Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
AVTX Total Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -54.3% | +38.4% |
| 3 y3 years | -53.0% | +34.5% |
| 5 y5 years | +15.7% | +158.9% |
AVTX Total Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -71.0% | at low | -40.5% | +228.9% |
| 5 y | 5-year | -71.0% | +5.1% | -57.8% | +228.9% |
| alltime | all time | -71.0% | +130.4% | -57.8% | +406.0% |
Avalo Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $13.11 M(+38.4%) |
| Jun 2024 | - | $9.47 M(+81.1%) |
| Mar 2024 | - | $5.23 M(+21.0%) |
| Dec 2023 | $25.37 M(-54.3%) | $4.32 M(+8.4%) |
| Sep 2023 | - | $3.99 M(-48.9%) |
| Jun 2023 | - | $7.79 M(-15.9%) |
| Mar 2023 | - | $9.27 M(-5.0%) |
| Dec 2022 | $55.49 M(-36.6%) | $9.75 M(-10.2%) |
| Sep 2022 | - | $10.85 M(-15.6%) |
| Jun 2022 | - | $12.86 M(-41.6%) |
| Mar 2022 | - | $22.03 M(+21.1%) |
| Dec 2021 | $87.53 M(+62.1%) | $18.18 M(+2.1%) |
| Sep 2021 | - | $17.81 M(-13.0%) |
| Jun 2021 | - | $20.48 M(-34.0%) |
| Mar 2021 | - | $31.05 M(+74.1%) |
| Dec 2020 | $53.99 M(+123.6%) | $17.84 M(+24.0%) |
| Sep 2020 | - | $14.39 M(+9.4%) |
| Jun 2020 | - | $13.15 M(+52.6%) |
| Mar 2020 | - | $8.62 M(+36.7%) |
| Dec 2019 | $24.14 M | $6.30 M(+24.5%) |
| Sep 2019 | - | $5.06 M(-3.0%) |
| Jun 2019 | - | $5.22 M(-31.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $7.56 M(-276.5%) |
| Dec 2018 | $21.93 M(+57.5%) | -$4.28 M(-145.5%) |
| Sep 2018 | - | $9.42 M(+6.8%) |
| Jun 2018 | - | $8.82 M(+10.6%) |
| Mar 2018 | - | $7.97 M(+21.0%) |
| Dec 2017 | $13.92 M(-19.2%) | $6.59 M(+111.5%) |
| Sep 2017 | - | $3.12 M(+61.2%) |
| Jun 2017 | - | $1.93 M(-15.4%) |
| Mar 2017 | - | $2.28 M(+22.3%) |
| Dec 2016 | $17.23 M(+56.5%) | $1.87 M(-70.3%) |
| Sep 2016 | - | $6.28 M(+51.9%) |
| Jun 2016 | - | $4.14 M(-16.3%) |
| Mar 2016 | - | $4.94 M(+34.5%) |
| Dec 2015 | $11.01 M(-35.7%) | $3.68 M(+87.6%) |
| Sep 2015 | - | $1.96 M(-32.2%) |
| Jun 2015 | - | $2.89 M(+16.4%) |
| Mar 2015 | - | $2.48 M(-35.2%) |
| Dec 2014 | $17.12 M(+32.3%) | $3.83 M(-36.1%) |
| Sep 2014 | - | $6.00 M(+64.1%) |
| Jun 2014 | - | $3.66 M(+0.7%) |
| Mar 2014 | - | $3.63 M |
| Dec 2013 | $12.93 M | - |
FAQ
- What is Avalo Therapeutics annual total expenses?
- What is the all time high annual total expenses for Avalo Therapeutics?
- What is Avalo Therapeutics annual total expenses year-on-year change?
- What is Avalo Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly total expenses year-on-year change?
What is Avalo Therapeutics annual total expenses?
The current annual total expenses of AVTX is $25.37 M
What is the all time high annual total expenses for Avalo Therapeutics?
Avalo Therapeutics all-time high annual total expenses is $87.53 M
What is Avalo Therapeutics annual total expenses year-on-year change?
Over the past year, AVTX annual total expenses has changed by -$30.12 M (-54.28%)
What is Avalo Therapeutics quarterly total expenses?
The current quarterly total expenses of AVTX is $13.11 M
What is the all time high quarterly total expenses for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly total expenses is $31.05 M
What is Avalo Therapeutics quarterly total expenses year-on-year change?
Over the past year, AVTX quarterly total expenses has changed by +$3.64 M (+38.41%)